Clinical Pharmacokinetics of Ibuprofen

The First 30 Years

Abstract

Ibuprofen is a chiral nonsteroidal anti-inflammatory drug (NSAID) of the 2 arylpropionic acid (2-APA) class. A common structural feature of 2-APA NSAIDs is a sp 3-hybridised tetrahedral chiral carbon atom within the propionic acid side chain moiety with the S-(+)-enantiomer possessing most of the beneficial anti-inflammatory activity. Ibuprofen demonstrates marked stereoselectivity in its pharmacokinetics. Substantial unidirectional inversion of the R-(−) to the S-(+) enantiomer occurs and thus, data generated using nonstereospecific assays may not be extrapolated to explain the disposition of the individual enantiomers.

The absorption of ibuprofen is rapid and complete when given orally. The area under the plasma concentration-time curve (AUC) of ibuprofen is dose-dependent. Ibuprofen binds extensively, in a concentration-dependent manner, to plasma albumin. At doses greater than 600mg there is an increase in the unbound fraction of the drug, leading to an increased clearance of ibuprofen and a reduced AUC of the total drug. Substantial concentrations of ibuprofen are attained in synovial fluid, which is a proposed site of action for nonsteroidal anti-inflammatory drugs.

Ibuprofen is eliminated following biotransformation to glucuronide conjugate metabolites that are excreted in urine, with little of the drug being eliminated unchanged. The excretion of conjugates may be tied to renal function and the accumulation of conjugates occurs in end-stage renal disease. Hepatic disease and cystic fibrosis can alter the disposition kinetics of ibuprofen. Ibuprofen is not excreted in substantial concentrations into breast milk.

Significant drug interactions have been demonstrated for aspirin (acetylsalicylic acid), cholestyramine and methotrexate. A relationship between ibuprofen plasma concentrations and analgesic and antipyretic effects has been elucidated.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Adams SS, Cliffe EE, Lessel B, et al. Some biological properties of 2-(4-isobutylphenyl)propionic acid [short report]. J Pharm Sci. 1967; 56: 1686.

    PubMed  CAS  Article  Google Scholar 

  2. 2.

    Adams SS, Bresloff P, Mason CG. Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (−)-isomer. J Pharm Pharmacol. 1976; 28: 256–7.

    PubMed  CAS  Article  Google Scholar 

  3. 3.

    Geisslinger G, Stock KP, Bach GL, et al. Pharmacological differences between R(−)- and S(+)-ibuprofen. Agents Actions. 1989; 27: 455–7.

    PubMed  CAS  Article  Google Scholar 

  4. 4.

    Evans AM. Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol. 1992; 42: 237–56.

    PubMed  CAS  Article  Google Scholar 

  5. 5.

    Villaneuva M, Heckenberger R, Strobach H, et al. Equipotent inhibition by R(−)-, S(+)- and racemic ibuprofen of human polymorphonuclear cell function in vitro. Br J Clin Pharmacol. 1993; 35: 235–42.

    Article  Google Scholar 

  6. 6.

    Evans AM, Nation RL, Sansom LN, et al. Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane synthesis and the plasma unbound concentration of S(+)-ibuprofen. Br J Clin Pharmacol. 1991; 31: 131–8.

    PubMed  CAS  Article  Google Scholar 

  7. 7.

    Busson M. Update on ibuprofen: review article. J Int Med Res. 1986; 14: 53–62.

    PubMed  CAS  Google Scholar 

  8. 8.

    Davies EF, Avery GS. Ibuprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic disorders. Drugs. 1971; 2: 416–46.

    PubMed  CAS  Article  Google Scholar 

  9. 9.

    Verbeeck RK. Pathophysiologic factors affecting the pharmacokinetics of nonsteroidal antiinflammatory drugs. J Rheumatol 1988; 17 Suppl.: 44–57.

    CAS  Google Scholar 

  10. 10.

    Davies NM. Clinical pharmacokinetics of flurbiprofen and its enantiomers. Clin Pharmacokinet. 1995; 28: 100–14.

    PubMed  CAS  Article  Google Scholar 

  11. 11.

    Davies NM. Clinical pharmacokinetics of tiaprofenic acid and its enantiomers. Clin Pharmacokinet. 1996; 31: 331–47.

    PubMed  CAS  Article  Google Scholar 

  12. 12.

    Brocks DR, Jamali F. Etodolac clinical pharmacokinetics. Clin Pharmacokinet. 1994; 26: 259–74.

    PubMed  CAS  Article  Google Scholar 

  13. 13.

    Brocks DR, Jamali F. Clinical Pharmacokinetics of ketorolac tromethamine. Clin Pharmacokinet. 1992; 23: 415–27.

    PubMed  CAS  Article  Google Scholar 

  14. 14.

    Jamali F, Brocks DR. Clinical pharmacokinetics of ketoprofen and its enantiomers. Clin Pharmacokinet. 1990; 19: 197–217.

    PubMed  CAS  Article  Google Scholar 

  15. 15.

    Davies NM, Anderson KE. Clinical pharmacokinetics of naproxen. Clin Pharmacokinet. 1997; 32: 268–93.

    PubMed  CAS  Article  Google Scholar 

  16. 16.

    Kaiser DG, Vangiessen GJ. GLC determination of ibuprofen [(±)-2-(p-isobutylphenyl)propionic acid in plasma. J Pharm Sci. 1974; 63: 219–21.

    PubMed  CAS  Article  Google Scholar 

  17. 17.

    Fujise H. A simple and sensitive colorimetric determination of ibuprofen from plasma and urine in dogs after dosing. Jpn J Vet Sci. 1977; 39: 671–3.

    CAS  Article  Google Scholar 

  18. 18.

    Hoffman DJ. Rapid GLC determination of ibuprofen in serum. J Pharm Sci. 1977; 66: 749–50.

    PubMed  CAS  Article  Google Scholar 

  19. 19.

    Midha KK, Cooper JK, Hubbard JW, et al. A rapid and simple GLC procedure for determinations of plasma concentrations of ibuprofen. Can J Pharm Sci. 1977; 12: 29–31.

    CAS  Google Scholar 

  20. 20.

    Hackett LP, Dusci LJ. Gas-liquid Chromatographic determination of ibuprofen in human plasma. Clin Chim Acta. 1978; 87: 301–3.

    PubMed  CAS  Article  Google Scholar 

  21. 21.

    Kaiser DG, Martin RS. Electron-capture GLC determination of ibuprofen in serum. J Pharm Sci. 1978; 67: 627–30.

    PubMed  CAS  Article  Google Scholar 

  22. 22.

    Singh NN, Pasutto FM, Coutts RT, et al. Gas Chromatographic separation of optically active anti-inflammatory 2-arylpropionic acids using (+)- or (−)-amphetamine as derivatizing reagent. J Chromatogr. 1986; 378: 125–35.

    PubMed  CAS  Article  Google Scholar 

  23. 23.

    Dusci LJ, Hackett LP. Determination of some anti-inflammatory drugs in serum by high-performance liquid chromatography. J Chromatogr. 1979; 172: 516–9.

    PubMed  CAS  Article  Google Scholar 

  24. 24.

    Pitrè D, Grandi M. Rapid determination of ibuprofen in plasma by high-performance liquid chromatography. J Chromatogr. 1979; 170: 278–81.

    PubMed  Article  Google Scholar 

  25. 25.

    Runci FM, Segre G. Gas Chromatographic determination of ibuprofen in plasma and in biological fluids. Chromatogr Symp Ser. 1979; 1: 199–201.

    CAS  Google Scholar 

  26. 26.

    Orzalesi G, Mari F, Bertol E, et al. Anti-inflammatory agents: determination of ibuproxam and its metabolite in humans. Arzneimittel Forschung. 1980; 30: 1607–9.

    PubMed  CAS  Google Scholar 

  27. 27.

    Ali A, Kazmi S, Plakogiannis FM. High-pressure liquid Chromatographic determination of ibuprofen in plasma. J Pharm Sci. 1981; 70: 944–5.

    PubMed  CAS  Article  Google Scholar 

  28. 28.

    Kearns GL, Wilson JT. Determination of ibuprofen in serum by high-performance liquid chromatography and application to ibuprofen disposition. J Chromatogr. 1981; 226: 183–90.

    PubMed  CAS  Article  Google Scholar 

  29. 29.

    Shimek JL, Rao NGS, Khalil SK. High-pressure liquid Chromatographie determination of ibuprofen in plasma. J Pharm Sci. 1981; 70: 514–6.

    PubMed  CAS  Article  Google Scholar 

  30. 30.

    Snider BG, Beaubien LJ, Sears DJ, et al. Determination of flurbiprofen and ibuprofen in dog serum with automated sample preparation. J Pharm Sci. 1981; 70: 1347–9.

    PubMed  CAS  Article  Google Scholar 

  31. 31.

    Lockwood GF, Wagner JG. High-performance liquid Chromatographie determination of ibuprofen and its major metabolites in biological fluids. J Chromatogr. 1982; 232: 335–43.

    PubMed  CAS  Article  Google Scholar 

  32. 32.

    Aarons L, Grennan DM, Siddiqui M. The binding of ibuprofen to plasma proteins. Eur J Clin Pharmacol. 1983; 25: 815–8.

    PubMed  CAS  Article  Google Scholar 

  33. 33.

    Ford B, Vine J, Watson TR. A rapid extraction method for acidic drugs in hemolyzed blood. J Anal Toxicol. 1983; 7: 116–8.

    PubMed  CAS  Google Scholar 

  34. 34.

    Hirai T, Matsumoto S, Kishi I. Simultaneous analysis of several non-steroidal anti-inflammatory drugs in urine by high-performance liquid chromatography with normal-phase extraction. J Chromatogr B 1997; 375–88.

  35. 35.

    Greenblatt DJ, Arendt RM, Locniskar A. Ibuprofen pharmacokinetics: use of liquid chromatography with radial compression separation. Arzneimittel Forschung. 1983; 33: 1671–3.

    PubMed  CAS  Google Scholar 

  36. 36.

    Senekjian HO, Leee CS, Kuo TH, et al. Absorption and disposition of ibuprofen in hemodialyzed uremic patients. Eur J Rheumatol Inflamm. 1983; 6: 155–62.

    PubMed  CAS  Google Scholar 

  37. 37.

    Heikkinen L. Quantitative determination of ibuprofen by glass capillary gas chromatography using three different methylation methods. Acta Pharm Fenn. 1983; 92: 275–82.

    CAS  Google Scholar 

  38. 38.

    Albert KS, Raabe A, Garry M, et al. Determination of ibuprofen in capillary and venous plasma by high-performance liquid chromatography with ultraviolet detection. J Pharm Sci. 1984; 73: 1487–9.

    PubMed  CAS  Article  Google Scholar 

  39. 39.

    Aravind MK, Miceli JN, Kauffman RE. Determination of ibuprofen by high-performance liquid chromatography. J Chormatogr. 1984; 308: 350–3.

    CAS  Article  Google Scholar 

  40. 40.

    Heikkinen L. Silica caplillary gas Chromatographic determination of ibuprofen in serum. J Chromatogr. 1984; 307: 206–9.

    PubMed  CAS  Article  Google Scholar 

  41. 41.

    Litowitz H, Olanoff L, Hoppel CL. Determination of ibuprofen in human plasma by high-performance liquid chromatography. J Chromatogr. 1984; 311: 443–8.

    PubMed  CAS  Article  Google Scholar 

  42. 42.

    Chan EM, Chan SC. Screening for acidic and neutral drugs by high performance liquid chromatography in post-mortem blood. J Anal Toxicol. 1984; 8: 173–6.

    PubMed  CAS  Google Scholar 

  43. 43.

    Ginman R, Karnes HT, Perrin J. Simultaneous determination of codeine and ibuprofen by high-performance liquid chromatography. J Pharm Biomed Anal. 1985; 3: 439–45.

    PubMed  CAS  Article  Google Scholar 

  44. 44.

    Jonkman HG, Schoenmaker R, Holtkamp AH, et al. Determination of ibuprofen in human plasma by solid phase extraction and reversed-phase high-performance liquid chromatography. J Pharm Biomed Anal. 1985; 3: 433–8.

    PubMed  CAS  Article  Google Scholar 

  45. 45.

    Giachetti C, Canali S, Zanolo G. Separation of non-steroidal anti-inflammatory agents by high-resolution gas chromatography. Preliminary trials to perform pharmacokinetic studies. J Chromatogr. 1983; 279: 587–92.

    CAS  Google Scholar 

  46. 46.

    Levine B, Caplan YH. Simultaneous liquid-chromatographic determination of five nonsteroidal anti-inflammatory drugs in plasma or blood. Clin Chem. 1985; 31: 346–47.

    PubMed  CAS  Google Scholar 

  47. 47.

    Shah A, Jung D. Improved high-performance liquid Chromatographie assay of ibuprofen in plasma. J Chormatogr. 1985; 344: 408–11.

    CAS  Article  Google Scholar 

  48. 48.

    Lee EJD, Williams KM, Graham GG, et al. Liquid Chromatographie determination and plasma concentration profile of optical isomers of ibuprofen in humans. J Pharm Sci. 1984; 73: 1542–4.

    PubMed  CAS  Article  Google Scholar 

  49. 49.

    Averginos A, Hutt AJ. High-performance liquid Chromatographie determination of ibuprofen in human plasma and urine by direct injection. J Chromatogr. 1986; 380: 468–71.

    Article  Google Scholar 

  50. 50.

    LaLande M, Wilson DL, MCGilveray IJ. Rapid high-performance liquid Chromatographic determination of ibuprofen in human plasma. J Chromatogr. 1986; 377: 410–4.

    PubMed  CAS  Article  Google Scholar 

  51. 51.

    Omile CI, Tebett IR. Determination of ten anti-inflammatory drugs in serum by isocratic liquid chromatography. Chromatographia. 1986; 22: 1–6.

    Article  Google Scholar 

  52. 52.

    Young MA, Aarons L, Davidson EM, et al. Stereospecific assay of ibuprofen and its metabolites [abstract]. J Pharm Pharmacol. 1986; 38: 60.

    Article  Google Scholar 

  53. 53.

    Kaluzny BD, Bannow CA. High-performance liquid Chromatographie determination of pimeprofen and its metabolite ibuprofen in sheep plasma and lymph. J Chromatogr. 1987; 414: 228–34.

    PubMed  CAS  Article  Google Scholar 

  54. 54.

    Moore CM, Tebbett IR. Rapid extraction of anti-inflammatory drugs in whole blood for HPLC analysis. Forsenic Sci Int. 1987; 34: 155–8.

    CAS  Article  Google Scholar 

  55. 55.

    Owen SG, Roberts MS, Freisen WT. Rapid high-performance liquid Chromatographic assay for the simultaneous analysis of non-steroidal anti-inflammatory drugs in plasma. J Chromatogr. 1987; 416: 293–302.

    PubMed  CAS  Article  Google Scholar 

  56. 56.

    Chai B, Minkler PE, Hoppel CI. Determination of ibuprofen and its major metabolites in human urine by high-performance liquid chromatography. J Chromatogr. 1988; 430: 93–101.

    PubMed  CAS  Article  Google Scholar 

  57. 57.

    Karnes HT, Rajasekharaiah K, Small RE, et al. Automated solid phase extraction and HPLC analysis of ibuprofen in plasma. J Liq Chromatogr. 1988; 11: 489–9.

    CAS  Article  Google Scholar 

  58. 58.

    Berner G, Engels B, Vogtle-Junkert U. Percutaneous ibuprofen therapy with trauma-dolgit gel: bioequivalence studies. Drugs Expt Clin Res. 1989; 15: 559–64.

    CAS  Google Scholar 

  59. 59.

    Lapique F, Netter P, Bannwarth B, et al. Identification and simultantaneous determination of non-steroidal anti-inflammatory drugs using high-performance liquid chromatography. J Chromatogr. 1989; 496: 301–20.

    Article  Google Scholar 

  60. 60.

    Satterwhite JH, Boudinot FD. High-performance liquid Chromatographic determination of ibuprofen in rat and human plasma. J Chromatogr. 1989; 497: 330–5.

    PubMed  CAS  Article  Google Scholar 

  61. 61.

    Schulz M, Schmoldt A. Determination of nonsteroidal anti-inflammatory drugs in human plasma by high-performance liquid chromatography. Pharm Ztg Wiss. 1989; 134: 41–4.

    Google Scholar 

  62. 62.

    Streete PJ. Rapid high-performance liquid Chromatographic methods for the determination of some non-steroidal anti-inflammatory drugs in plasma or serum. J Chromatogr. 1989; 495: 179–93.

    PubMed  CAS  Article  Google Scholar 

  63. 63.

    Berner G, Staab R, Wagener HH. Determination of ibuprofen in plasma, synovial fluid and tissue by HPLC with electrochemical detection in the lower ng-range. Fresenius J Anal Chem. 1990; 336: 238.

    CAS  Article  Google Scholar 

  64. 64.

    Marzo A, Reiner A, Monti N, et al. Evaluation of ibuprofen dimethylaminoethanol octyl bromide and related active metabolites in biological samples. Arzneimittel Forschung. 1990; 40: 614–7.

    PubMed  CAS  Google Scholar 

  65. 65.

    Rustum AM. Measurement of ibuprofen in human whole blood by reversed-phase ion-paired high-performance liquid chromatography using a pH-stable polymeric column. J Chromatogr. 1990; 526: 246–53.

    PubMed  CAS  Article  Google Scholar 

  66. 66.

    Nahata MC. Determination of ibuprofen in human plasma by high-performance liquid chromatography. J Liq Chromatogr. 1991; 14: 187–92.

    CAS  Article  Google Scholar 

  67. 67.

    Rustum AM. Assay of ibuprofen in human plasma by rapid and sensitive reversed-phase high-performance liquid chromaography: application to a single dose pharmacokinetic study. J Chromatogr Sci. 1991; 29: 16–20.

    PubMed  CAS  Google Scholar 

  68. 68.

    Yamashita K, Motohashi M, Yashiki T. Column-switching techniques for high-performance liquid chromatography of ibuprofen and mefenamic acid in human serum with short-wavelength ultraviolet detection. J Chromatogr. 1991; 570: 329–38.

    PubMed  CAS  Article  Google Scholar 

  69. 69.

    Blagbrough IS, Daykin MM, Doherty M, et al. PN. High-performance liquid Chromatographic determination of diclofenac, ibuprofen and diclofenac in plasma and synovial fluid in man. J Chromatogr. 1992; 578: 251–7.

    PubMed  CAS  Article  Google Scholar 

  70. 70.

    Jack DS, Rumble RH, Davies NW, et al. Enantiospecific gas chromatographic-mass spectrometric procedure for the determination of ketoprofen and ibuprofen in synovial fluid and plasma: application to protein binding studies. J Chromatogr. 1992; 584: 189–97.

    PubMed  CAS  Article  Google Scholar 

  71. 71.

    Jung ES, Lee HS, Rho JK et al. Simultaneous determination of ibuproxam and ibuprofen in human plasma by HPLC with column switching. Chromatographia. 1993; 37: 618–22.

    CAS  Article  Google Scholar 

  72. 72.

    Zhao M-J, Peter C, Holtz M-C, et al. Gas chromatographic-mass spectrometric determination of ibuprofen enantiomers in human plasma using R(−)-2,2,2-trifluoro-1-(9-anthryl)ethanol as derivatizing reagent. J Chromatogr. 1994; 656: 441–6.

    CAS  Article  Google Scholar 

  73. 73.

    Steijger OM, Lingeman H, Brinkman UAT, et al. Liquid Chromatographic analysis of carboxylic acids uszng N-(4-aminobutyl)-N-ethylisoluminol as chemiluminescent label: determination of ibuprofen in saliva. J Chromatogr. 1993; 615: 97–110.

    PubMed  CAS  Article  Google Scholar 

  74. 74.

    Kim K-R, Shim W-H, Shin Y-J, et al. Capillary gas chromatography of acidic non-steroidal antiinflammatory drugs as tertbutyldimethylsilyl derivatives. J Chromatogr. 1993; 641: 319–27.

    CAS  Article  Google Scholar 

  75. 75.

    Rifai N, Sakamoto M, Law T, et al. Use of a rapid HPLC assay for determination of pharmacokinetic parameters of ibuprofen in patients with cystic fibrosis. Clin Chem. 1994; 42: 1812–6.

    Google Scholar 

  76. 76.

    Wilson WH. Direct enantiomeric resolution of ibuprofen and flurbiprofen by packed column SFC. Chirality. 1994; 6: 216–9.

    CAS  Article  Google Scholar 

  77. 77.

    Kim K-R, Shin Y-J, Shim W-H, et al. Rapid gas Chromatographie profiling and screening of acidic non-steroidal anti-inflammatory drugs in biological samples. Arch Pharm Res. 1994; 17: 175–81.

    CAS  Article  Google Scholar 

  78. 78.

    Vangiessen GJ, Kaiser DG. GLC determination of ibuprofen [dl-2-(p-isobutylphenyl)propionic acid] enantiomers in biological specimens. J Pharm Sci. 1975; 64: 798–801.

    PubMed  CAS  Article  Google Scholar 

  79. 79.

    Crowther JB, Covey TR, Dewey EA, et al. Liquid chromatographic/mass spectrometric determination of optically active drugs. Anal Chem. 1984; 56: 2921–6.

    PubMed  CAS  Article  Google Scholar 

  80. 80.

    Giachetti C, Zanolo G, Canali S. Topical administration of ibuprofen in man: simultaneous determination of the drug and its metabolites in urine by high resolution gas chromatography. J High Res Chromatogr Commun. 1985; 8: 465–8.

    CAS  Article  Google Scholar 

  81. 81.

    Whitlam JB, Vine JH. Quantitation of ibuprofen in biological fluids by gas chromatography-mass spectrometry. J Chromatogr. 1980; 181: 463–8.

    PubMed  CAS  Article  Google Scholar 

  82. 82.

    Averginos A, Hutt AJ. Determination of the enantiomeric composition of ibuprofen in human plasma by high-performance liquid chromatography. J Chromatogr. 1987; 415: 75–83.

    Article  Google Scholar 

  83. 83.

    Minkler PE, Hoppel CL. Determination of ibuprofen in human plasma by high-perfomance liquid chromatography. J Chromatogr. 1988; 428: 388–94.

    PubMed  CAS  Article  Google Scholar 

  84. 84.

    Nicoll-Griffith DA, Inaba T, Tang BK, et al. Method to determine the enantiomers of ibuprofen from humna urine by high-performance liquid chromatography. J Chromatogr. 1988; 428: 103–12.

    PubMed  CAS  Article  Google Scholar 

  85. 85.

    Mehvar R, Jamali F, Pasutto FM. Liquid-chromatographic assay of ibuprofen enantiomers in plasma. Clin Chem. 1988; 34: 493–6.

    PubMed  CAS  Google Scholar 

  86. 86.

    Geisslinger G, Dietzel K. High-performance liquid Chromatographie determination of ibuprofen, its metabolites and enantiomers in biological fluids. J Chromatogr. 1989; 491: 139–49.

    PubMed  CAS  Article  Google Scholar 

  87. 87.

    Martin W, Koselowske G, Toberich H, et al. Pharmacokinetics and absolute bioavailability of ibuprofen after oral administration of ibuprofen lysine in man. Biopharm Drug Disp. 1990; 11: 265–78.

    CAS  Article  Google Scholar 

  88. 88.

    Menzel-Soglowek S, Geisslinger G, Brune K. Stereoselective high-performance liquidchromatographic determination of ketoprofen, ibuprofen and fenoprofen in plasma using a chiral α1-acid glycoprotein column. J Chromatogr. 1990; 532: 295–303.

    PubMed  CAS  Article  Google Scholar 

  89. 89.

    Pettersson K-J, Olsson A. Liquid Chromatographic determination of the enantiomers of ibuprofen in plasma using a chiral AGP column. J Chromatogr. 1991; 563: 414–8.

    PubMed  CAS  Article  Google Scholar 

  90. 90.

    Theis DL, Halstead GW, Halm KA. Development of capillary gas chromaotgraphic-mass spectrometric methodology for the simultaneous determination of ibuprofen and [ar-2H4] ibuprofen in serum: demonstration of kinetic equivalence in the beagle. J Chromatogr. 1986; 380: 77–87.

    PubMed  CAS  Article  Google Scholar 

  91. 91.

    Wright MR, Sattari S, Brocks DR, et al. Improved high-performance liquid Chromatographic assay method for the enantiomers of ibuprofen. J Chromatogr. 1992; 583: 259–65.

    PubMed  CAS  Article  Google Scholar 

  92. 92.

    Lemko CH, Caillé G, Foster RT. Stereospecific high-performance liquid Chromatographic assay of ibuprofen: improved sensitivity and sample processing efficiency. J Chromatogr. 1993; 619: 330–5.

    PubMed  CAS  Article  Google Scholar 

  93. 93.

    Ahn H-Y, Shiu GK, Trafton WF, et al. Resolution of the enantiomers of ibuprofen; comparison study of diastereomeric method and chiral stationary phase method. J Chromatogr B. 1994; 653: 163–9.

    CAS  Article  Google Scholar 

  94. 94.

    De Vries JX, Schmitz-Kummer E, Siemon D. The analysis of ibuprofen enantiomers in human plasma and urine by high-performance liquid chromatography on an α1-acid glycoprotein chiral stationary phase. J Liq Chromatogr. 1994; 17: 2127–45.

    Article  Google Scholar 

  95. 95.

    Kondo J, Suzuki N, Naganuma H, et al. Enantiospecific determination of ibuprofen in rat plasma using chiral fluorescence derivatization reagent, (−)-2-[4-(1-aminoethyl)-phenyl]-6-methoxybenzoxazole. Biomed Chromatogr. 1994; 8: 170–4.

    PubMed  CAS  Article  Google Scholar 

  96. 96.

    Naidong W, Lee JW. Development and validation of a liquid Chromatographic method for the qunatitation of ibuprofen enantiomers in human plasma. J Pharm Biomed Anal. 1994; 12: 551–6.

    PubMed  CAS  Article  Google Scholar 

  97. 97.

    Kunsman GW, Rohrig TP. Tissue distribution of ibuprofen in a fatal overdose. Am J Forensic Med Pathol. 1993; 14: 48–50.

    PubMed  CAS  Article  Google Scholar 

  98. 98.

    Péhourcq F, Lagrange F, Labat L, et al. Simultaneous measurement of flurbiprofen, ibuprofen, and ketoprofen enantiomer concentrations in plasma using L-leucinamide as the chiral coupling component. J Liq Chromatorgr. 1995; 18: 3969–79.

    Article  Google Scholar 

  99. 99.

    Gabard B, Nirnberger G, Schiel H, et al. Comparison of the bioavailability of dexibuprofen administered alone or as part of racemic ibuprofen. Eur J Clin Pharmacol. 1995; 48: 505–11.

    PubMed  CAS  Article  Google Scholar 

  100. 100.

    Lau YY. Determination of ibuprofen enantiomers in human plasma by derivatization and high performance liquid chromatography with fluoresence detection. J Liq Chromatogr Rel Technol. 1996; 19: 2143–53.

    CAS  Article  Google Scholar 

  101. 101.

    Terfloth GJ, Pirkle WH, Lynam KG, et al. Broadly applicable polysiloxane-based chiral stationary phase for high-performance liquid chromatography and supercritical fluid chromatography. J Chromatogr. 1995; 705: 185–94.

    CAS  Article  Google Scholar 

  102. 102.

    Suzuki N, Naganuma H, Kondo J, et al. Enantiospecific determination of ibuprofen in rat plasma using chiral fluorescence derivatization reagent, (−)-2-[4-(1-Aminoethyl)phenyl]-6-methoxybenzoxazole [abstract]. Int Symp Mol Chir. 1994; 524: 314.

    Google Scholar 

  103. 103.

    Askholt J, Nielsen-Kudsk F. Rapid HPLC-Determination of ibuprofen and flurbiprofen in plasma for therapeutic drug control and pharmacokinetic applications. Acta Pharmacol Toxicol. 1986; 59: 282–6.

    Google Scholar 

  104. 104.

    Sochor J, Klimes J, Zahradnicke M, et al. High-Performance liquid chromaotgraphic assay for ibuprofen in whole blood using soli-phase extraction. J Chromatogr. 1994; 654: 282–6.

    CAS  Article  Google Scholar 

  105. 105.

    Brooks CJW, Gilbert MT. Studies of urinary metabolites of 2-(4-isobutylphenyl)propionic acid by gas-liquid chromatography-mass spectrometry. J Chromatogr. 1974; 99: 541–51.

    PubMed  CAS  Article  Google Scholar 

  106. 106.

    Maurer HH, Kraemer T, Weber A. Toxicological detection of ibuprofen and its metabolites in urine using gas chromatography-mass spectrometry (GC-MS). Pharmazie. 1994; 49: 148–50.

    PubMed  CAS  Google Scholar 

  107. 107.

    Save TK, Parmar DV, Devarajan PV. High-performance thinlayer Chromatographic determination of ibuprofen in plasma. J Chromatogr. 1997; 690: 315–9.

    CAS  Article  Google Scholar 

  108. 108.

    Davies NM. Methods of analysis of chiral non-steroidal anti-inflammatory drugs. J Chromatogr B. 1997; 691: 229–62.

    CAS  Article  Google Scholar 

  109. 109.

    D’Hulst A, Verbeke N. Chiral separation by capillary electrophoresis with oligosaccharides. J Chromatogr. 1992; 608: 275–87.

    PubMed  Article  Google Scholar 

  110. 110.

    Maboundou CW, Paintaud G, Berard M, et al. Separation of fifteen non-steroidal anti-inflammatory drugs using micellar electrokinetic capillary chromatography. J Chromatogr B. 1994; 657: 173–83.

    CAS  Article  Google Scholar 

  111. 111.

    Petersson P, Markides KE. Chiral separations performed by supercritical fluid chromatography. J Chromatogr. 1994; 666: 381–94.

    CAS  Article  Google Scholar 

  112. 112.

    Shihabi ZK, Hinsdale ME. Analysis of ibuprofen in serum by capillary electrophoresis. J Chromatogr. 1996; 683: 115–8.

    CAS  Article  Google Scholar 

  113. 113.

    Bhushan R, Parshad V. Resolution of (±)-ibuprofen using L-arginine-impregnated thin-layer chromatography. J Chromatogr. 1996; 721: 369–72.

    CAS  Article  Google Scholar 

  114. 114.

    Toyo’oka T, Ishibashi M, Terao T. Resolution of carboxylic acid enantiomers by high-performance liquid chromaogrpahy with peroxylate chemiluminescence. J Chromatogr. 1997; 627: 75–86.

    Google Scholar 

  115. 115.

    Mills RFN, Adams SS, Cliffe EE, et al. The metabolism of ibuprofen. Xenobiotica. 1973; 9: 589–98.

    Article  Google Scholar 

  116. 116.

    Collier PS, D’Arcy PF, Harron DWG, et al. Pharmacokinetic modelling of ibuprofen. Br J Clin Pharmacol. 1978; 5: 528–30.

    PubMed  CAS  Article  Google Scholar 

  117. 117.

    Mäkelä A-L, Lempiäinen M, Yrjänä T. Ibuprofen in the treatment of juvenile rheumatoid arthritis: metabolism and concentrations in synovial fluid. Br J Clin Pract. 1980; 6: 23–7.

    Google Scholar 

  118. 118.

    Mäkelä A-L, Lempiäinen M, Ylijoki H. Ibuprofen levels in serum and synovial fluid. Scand J Rheumatol. 1981; 39: 15–7.

    Article  Google Scholar 

  119. 119.

    Barillari G, Iorio E, Catanese B, et al. A study of the absorption and tolerance of ibuprofen guaiacol ester in man after repeated oral administration. Boll Chim Farm. 1982; 121: 626–31.

    PubMed  CAS  Google Scholar 

  120. 120.

    Catanese B, Barillari G, Iorio E, et al. Studies on the oral absorption of ibuprofen guaiacol-ester in man. Boll Chim Farm. 1982; 121: 567–72.

    PubMed  CAS  Google Scholar 

  121. 121.

    Gillespie WR, DiSanto AR, Monovich RE, et al. Relative bioavailability of commercially available ibuprofen oral dosage forms in humans. J Pharm Sci. 1982; 71: 1034–8.

    PubMed  CAS  Article  Google Scholar 

  122. 122.

    Zanola G, Mondino A, Giachetti G, et al. Humankinetische Untersuchungen mit ibuprofen. Therapiewoche. 1982; 32: 4353–7.

    Google Scholar 

  123. 123.

    Aarons L, Greenan DM, Rajapakse C, et al. Anti-inflammatory (ibuprofen) drug therapy in rheumatoid arthritis: rate of response and lack of time dependency of plasma pharmacokinetics. Br J Clin Pharmac. 1983; 15: 387–8.

    CAS  Article  Google Scholar 

  124. 124.

    Juhl RP, Van Thiel DH, Dittert LW, et al. Ibuprofen and sulindac kinetics in alcoholic liver disease. Clin Pharmacol Ther. 1983; 34: 104–9.

    PubMed  CAS  Article  Google Scholar 

  125. 125.

    Lockwood GF, Albert KS, Gillespie WR, et al. Pharmacokinetics of ibuprofen in man. 1: free and total area/dose relationships. Clin Pharmacol Ther. 1983; 31: 97–103.

    Google Scholar 

  126. 126.

    Stead JA, Freeman M, John EG, et al. Ibuprofen tablets: dissolution and bioavailability studies. Int J Pharm. 1983; 14: 59–72.

    CAS  Article  Google Scholar 

  127. 127.

    Wright CE, Antal EJ, Gillespie WR, et al. Ibuprofen and acetaminophen kinetics when taken concurrently. Clin Pharmacol Ther. 1983; 34(5): 707–10.

    PubMed  CAS  Article  Google Scholar 

  128. 128.

    Zanola G, Mondino A, Giachetti G, et al. Ibuprofen-serumkonzentration nach oraler applikation von Dolgit® retard. Therapiewoche. 1983; 33: 2114–6.

    Google Scholar 

  129. 129.

    Albert KS, Gillespie WR, Wagner JG, et al. Effects of age on the clinical pharmacokinetics of ibuprofen. Am J Med. 1984; 6: 47–50.

    Article  Google Scholar 

  130. 130.

    Pugh MC, Small RE, Garnett WR, et al. Effect of sucralfate on ibuprofen absorption in normal volunteers. Clin Pharm. 1984; 3: 630–3.

    PubMed  CAS  Google Scholar 

  131. 131.

    Greenblatt DJ, Abernathy DR, Methis R, et al. Absorption and disposition of ibuprofen in the elderly. Arthritis Rheum. 1984; 27: 1066–9.

    PubMed  CAS  Article  Google Scholar 

  132. 132.

    Abernathy DR, Greenblatt DJ. Ibuprofen disposition in obese individuals. Arthritis Rheum. 1985; 28: 1117–21.

    Article  Google Scholar 

  133. 133.

    Gambaro V, Caligara M, Benvenuti C, et al. Pharmacokinetics of ibuprofen microincapsulated granules. II Farmaco. 1985; 40: 407–15.

    CAS  Google Scholar 

  134. 134.

    Ochs HR, Greenblatt DJ, Matlis R, et al. Interaction of ibuprofen with the H-2 receptor antagonists ranitidine and cimetidine. Clin Pharmacol Ther. 1985; 38: 648–51.

    PubMed  CAS  Article  Google Scholar 

  135. 135.

    Palva ES, Konno K, Venbo VMK. Bioavailability of ibuprofen from three preparations marketed in Finland. Acta Pharm Fenn. 1985; 94: 31–5.

    CAS  Google Scholar 

  136. 136.

    Anaya AL, Mayersohn M, Conrad KA, et al. The influence of sucralfate on ibuprofen absorption in healthy adult males. Biopharm Drug Disp. 1986; 7: 433–51.

    Article  Google Scholar 

  137. 137.

    Antal EJ, Wright CE, Brown BL, et al. The influence of hemodialysis on the pharmacokinetics of ibuprofen and its major metabolites. J Clin Pharmacol. 1986; 26: 184–90.

    PubMed  CAS  Google Scholar 

  138. 138.

    Benvenuti C, Cancellieri V, Gambaro V, et al. Pharmacokinetics of two new oral formulations of ibuprofen. In J Clin Pharmacol Toxicol. 1986; 24: 308–12.

    CAS  Google Scholar 

  139. 139.

    Gallo JM, Gall EP, Gillespie WR, et al. Ibuprofen kinetics in plasma and synovial fluid arthritic patients. J Clin Pharmacol. 1986; 26: 65–70.

    PubMed  CAS  Google Scholar 

  140. 140.

    Müller FO, Hundt HK, Van Dyk M, et al. Ibuprofen bioavailability: a comparison of brufen and inza. S Afr Med J. 1986; 70: 197–9.

    PubMed  Google Scholar 

  141. 141.

    Regazzi BM, Rondanelli R, Ciaroelli L, et al. Evaluation of the absorption from three formulations. Int Clin Pharm Res. 1986; 6: 469–73.

    CAS  Google Scholar 

  142. 142.

    Gontarz N, Small RE, Comstock TJ, et al. Effect of antacid suspension on the pharmacokinetics of ibuprofen. Clin Pharm. 1987; 6: 413–6.

    PubMed  CAS  Google Scholar 

  143. 143.

    Lau L-B, Feing-Fei M, Xi-De T. Studies on the bioavailability of ibuprofen tablets. Acta Pharm Sin. 1987; 22: 769–76.

    Google Scholar 

  144. 144.

    Parr AF, Beihn RM, Franz RM, et al. Correlation of ibuprofen bioavailability with gastrointestinal transit by scintigraphic monitoring of 171Er-labeled sustained-release tablets. Pharm Res. 1987; 4: 486–9.

    PubMed  CAS  Article  Google Scholar 

  145. 145.

    Berardi RR, Dressman JB, Elta GH, et al. Elevation of gastric pH with ranitidine does not affect the release characterisitcs of sustained release ibuprofen tablets. Biopharm Drug Disp. 1988; 9: 337–47.

    CAS  Article  Google Scholar 

  146. 146.

    Forsyth DR, Jayasinghe KSA, Roberts CJC. Do nizatidine and cimetidine interact with ibuprofen? Eur J Clin Pharmacol. 1988; 35: 85–8.

    PubMed  CAS  Article  Google Scholar 

  147. 147.

    Källström E, Heikinheimo M, Quiding H. Bioavailability of three commericial preparations of ibuprofen 600mg. J Int Med Res. 1988; 16: 44–9.

    PubMed  Google Scholar 

  148. 148.

    Small RE, Johnson SM, Willis HE. Pharmacokinetic and taste evaluation of ibuprofen (Motrin®) 800mg tablets in extemporaneous solution. J Rheumatol. 1988; 15: 345–7.

    PubMed  CAS  Google Scholar 

  149. 149.

    Stephenson DW, Small RE, Wood JH, et al. Effect of rantitidine and cimetidine on ibuprofen pharmacokinetics. Clin Pharm. 1988; 7: 317–21.

    PubMed  CAS  Google Scholar 

  150. 150.

    Eller MG, Wright C, Della-Coletta AA. Absorption kinetics of rectally and orally administered ibuprofen. Biopharm Drug Disp. 1989; 10: 269–78.

    CAS  Article  Google Scholar 

  151. 151.

    Sprekeler R, Baurecht W. Pharmakokinetische kennwerte unter therapie mit einem nichtsteroidalen antirheumatikum mit kurzer halbwertszeit bei patienten über 65 jahren. Arzneimittel Forschung. 1989; 39: 912–4.

    PubMed  CAS  Google Scholar 

  152. 152.

    Wilson CG, Washington N, Greaves JL, et al. Bimodal release of ibuprofen in a sustained-release formulation: a scintigraphic and pharmacokinetic open study in healthy volunteers under different conditions of food intake. Int J Pharm. 1989; 50: 155–61.

    CAS  Article  Google Scholar 

  153. 153.

    Borin MT, Khare S, Beihn RM, et al. The effect of food on gastrointestinal (GI) transit of sustained-release ibuprofen tablets as evaluated by gamma scintigraphy. Pharm Res. 1990; 7: 304–7.

    PubMed  CAS  Article  Google Scholar 

  154. 154.

    Freidman H, Lanza F, Perry K, et al. Clinical pharmacology of predisintegrated ibuprofen 800mg tablets: an endoscopic and pharmacokinetic study. J Clin Pharmacol. 1990; 30: 57–63.

    Google Scholar 

  155. 155.

    Hannula AM, Marvola M, Rajamaeki M, et al. Effects of pH regulators used as additives on the bioavailability of ibuprofen from hard gelatin capsules. Acta Pharm Fenn. 1990; 7: 221–7.

    Google Scholar 

  156. 156.

    Karttunen P, Saano V, Paronen P, et al. Pharmacokinetics of ibuprofen in man: a single-dose comparison of two over-the-counter, 200mg preparations. Int J Clin Pharmacol Ther Toxicol. 1990; 28: 251–5.

    PubMed  CAS  Google Scholar 

  157. 157.

    Kendall MJ, Jubb R, Bird HA, et al. A pharmacokinetic comparison of ibuprofen sustained-release tablets given to young and elderly patients. J Clin Pharm Ther. 1990; 15: 35–40.

    PubMed  CAS  Article  Google Scholar 

  158. 158.

    Lenhard G, Kieferndorf U, Berner G, et al. Pharmacokinetik un bioäquivalenz von zwei ibuprofen-formulierungen. Arzneimittel Forschung. 1990; 40: 1358–62.

    PubMed  CAS  Google Scholar 

  159. 159.

    Konstan MW, Hoppel CL, Chai B-L, et al. Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects. J Pediatr. 1991; 118: 956–64.

    PubMed  CAS  Article  Google Scholar 

  160. 160.

    Nahata MC, Durrell DE, Powell DA, et al. Pharmacokinetics of ibuprofen in febrile children. Eur J Clin Pharmacol. 1991; 40: 427–8.

    PubMed  CAS  Article  Google Scholar 

  161. 161.

    Neuvonen PJ. The effect of magnesium hydroxide on the oral absorption of ibuprofen, ketoprofen and diclofenac. Br J Clin Pharmacol. 1991; 31: 263–6.

    PubMed  CAS  Article  Google Scholar 

  162. 162.

    Saano V, Paronen P, Peura P, et al. Relative pharmacokinetics of three oral 400mg ibuprofen dosage forms in healthy volunteers. In J Clin Pharm Ther Toxicol. 1991; 29: 381–5.

    CAS  Google Scholar 

  163. 163.

    Salas-Herrera IG, Pearson RM, Turner P. Concentration of ibuprofen in cervical mucus. J Pharm Pharmacol. 1991; 43: 142–4.

    PubMed  CAS  Article  Google Scholar 

  164. 164.

    Small RE, Wilmot-Pater MG, McGee BA, et al. Effects of misoprostol or ranitidine on ibuprofen pharmacokinetics. Clin Pharm. 1991; 10: 870–2.

    PubMed  CAS  Google Scholar 

  165. 165.

    Brown RD, Wilson JT, Kearns GL, et al. Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children. J Clin Pharmacol. 1992; 32: 231–41.

    PubMed  CAS  Google Scholar 

  166. 166.

    Ceppi Monti N, Gazzaniga A, Gianesello V, et al. Activity and pharmacokinetics of a new oral dosage form of soluble ibuprofen. Arzneimittel Forschung. 1992; 42: 556–9.

    PubMed  CAS  Google Scholar 

  167. 167.

    Chen M-L. An alternative approach for assessment of rate of absorption in bioequivalence studies. Pharm Res. 1992; 9: 1380–5.

    PubMed  CAS  Article  Google Scholar 

  168. 168.

    Kauffman RE, Nelson MV. Effect of age on ibuprofen pharmacokinetics and antipyretic response. J Pediatr. 1992; 121: 969–73.

    PubMed  CAS  Article  Google Scholar 

  169. 169.

    Kelley MT, Walson PD, Edge JH, et al. Pharmacokinetics and pharmacodynamics of ibuprofen isomers and acetaminophen in febrile children. Clin Pharmacol Ther. 1992; 52: 181–9.

    PubMed  CAS  Article  Google Scholar 

  170. 170.

    Luckow V, Krammer R, Traub R. Vergleichende bioverfugbarkeitsuntersuchung zweier versciedener ibuprofen-granulate. Arzneimittel Forschung. 1992; 42: 1339–42.

    PubMed  CAS  Google Scholar 

  171. 171.

    Ragni MV, Miller BJ, Whalen R, et al. Bleeding tendency, platelet function, and pharmacokinetics of ibuprofen and zidovudine in HTV(+) hemophilie men. Am J Hem. 1992; 40: 176–82.

    CAS  Article  Google Scholar 

  172. 172.

    Cone JB, Wallace BH, Olsen KM, et al. The pharmacokinetics of ibuprofen after burn injury. J Burn Care Rehabil. 1993; 14: 666–9.

    PubMed  CAS  Article  Google Scholar 

  173. 173.

    Seth PL. Percutaneous absorption of ibuprofen from different fromulations: comparative study with gel, hydrophilic ointment and emulsion cream. Arzneimittel Forschung. 1993; 43: 919–21.

    PubMed  CAS  Google Scholar 

  174. 174.

    Al-Meshal MA, El-Sayed YM, Al-Balla SR, et al. The effect of colestipol and cholestyramine on ibuprofen bioavailability in man. Biopharm Drug Disp. 1994; 15: 463–71.

    CAS  Article  Google Scholar 

  175. 175.

    Kaltenbach ML, Mohammed SS, Mullersman G, et al. Pharmacokinetic evaluation of two ibuprofen-codeine combinations. Int J Clin Pharmacol Ther. 1994; 32: 210–4.

    PubMed  CAS  Google Scholar 

  176. 176.

    Rey E, Pariente-Khayat A, Gouyet L, et al. Stereoselective dispostition of ibuprofen enantiomers in infants. Br J Clin Pharmac. 1994; 38: 373–5.

    CAS  Article  Google Scholar 

  177. 177.

    El-Sayed YM, Gouda MW, Al-Khamis Kl, et al. Comparative bioavailability of two tablet formulations of ibuprofen. Int J Clin Pharmacol Ther. 1995; 33: 294–8.

    PubMed  CAS  Google Scholar 

  178. 178.

    Kleinbloesem CH, Owerkerk M, Spitznagel W, et al. Pharmacokinetics and bioavailability of percutaneous ibuprofen. Arzneimittel Forschung. 1995; 45: 1117–21.

    PubMed  CAS  Google Scholar 

  179. 179.

    Walter K, Weib G, Laicher A, et al. Pharmacokinetics of ibuprofen following a single administration of a suspension containing enteric-coated microcapsules. Arzneimittel Foschung. 1995; 45: 886–90.

    CAS  Google Scholar 

  180. 180.

    Ntawukulilyayo JD, Veraet C, Remon JP, et al. In vitro and in vivo evaluation of a xanthan gum-n-octenylsuccinate starch matrix tablet containing ibuprofen as a model drug. Int J Pharm. 1996; 139: 79–85.

    CAS  Article  Google Scholar 

  181. 181.

    Pargal A, Kelkar MG, Nayak PJ. The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations. Biopharm Drug Disp. 1996; 17: 511–9.

    CAS  Article  Google Scholar 

  182. 182.

    Wagener HH, Vögtle-Junkert U. Zur auswertung von wirkstoffkonzentration in geweben nach perkutaner anwendung von nicht-steroidalen antirheumatika. Arzneimittel Forschung. 1996; 46: 299–301.

    PubMed  CAS  Google Scholar 

  183. 183.

    Aranda JV, Varvarigou A, Beharry K, et al. Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Paediatr. 1997; 86: 289–93.

    PubMed  CAS  Article  Google Scholar 

  184. 184.

    Jones K, Seymour RA, Hawkesford JE. Are the pharmacokinetics of ibuprofen important determinants for the dru’s efficacy in postoperative pain after third molar surgery? Br J Oral Maxillofac Surg. 1997; 35(3): 173–6.

    PubMed  CAS  Article  Google Scholar 

  185. 185.

    Lee EJD, Williams KM, Day RO, et al. Stereoselective disposition of ibuprofen enantiomers in man. Br J Clin Pharmacol. 1985; 19: 669–74.

    PubMed  CAS  Article  Google Scholar 

  186. 186.

    Cox SR, Brown MA, Squires DJ, et al. Comparative human study of ibuprofen enantiomer plasma concentrations produced by two commercially available ibuprofen tablets. Biopharm Drug Disp. 1988; 9: 539–49.

    CAS  Article  Google Scholar 

  187. 187.

    Day RO, Williams KM, Graham GG, et al. Stereoselective disposition of ibuprofen enantiomers in synovial fluid. Clin Pharmacol Ther. 1988; 43: 480–7.

    PubMed  CAS  Article  Google Scholar 

  188. 188.

    Jamali F, Singh NN, Pasutto FM, et al. Pharmacokinetics of ibuprofen enantiomers in man following oral administration of tablets with different absorption rates. Pharm Res. 1988; 5: 40–3.

    PubMed  CAS  Article  Google Scholar 

  189. 189.

    Evans AM, Nation RL, Sansom LN. Lack of effect of cimetidine on the pharmacokinetics of R(−)- and S(+)-ibuprofen. Br J Clin Pharmacol. 1989; 28: 143–9.

    PubMed  CAS  Article  Google Scholar 

  190. 190.

    Baillie TA, Adams WJ, Kaiser DG, et al. Mechanistic studies of the metabolic chiral inversion of (R)-ibuprofen in humans. J Pharm Exp Ther. 1989; 249: 517–23.

    CAS  Google Scholar 

  191. 191.

    Li G, Treiber G, Klotz U. The ibuprofen-cimetidine interaction stereochemical considerations. Drug Invest. 1989; 1: 11–7.

    Google Scholar 

  192. 192.

    Averginos A, Hutt AJ. Interindividual variability in the enantiomeric disposition of ibuprofen follwing the oral administration of the racemic drug to healthy volunteers. Chirality. 1990; 2: 249–56.

    Article  Google Scholar 

  193. 193.

    Evans AM, Nation RI, Sansom LN, et al. The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humans. Biopharm Drug Dispos. 1990; 2: 507–18.

    Article  Google Scholar 

  194. 194.

    Geisslinger G, Schuster O, Stock KP, et al. Pharmacokinetics of S(+)- and R(−)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis. Eur J Clin Pharmacol. 1990; 38: 493–7.

    PubMed  CAS  Article  Google Scholar 

  195. 195.

    Cox SR, Gall EP, Forbes KK, et al. Pharmacokinetics of the R (−) and S(+) enantiomers of ibuprofen in the serum and synovial fluid of arthritic patients. J Clin Pharmacol. 1991; 31: 88–94.

    PubMed  CAS  Google Scholar 

  196. 196.

    Wagener HH, Kalbhen DA, Berner G, et al. Ibuprofen-racemate und enantiomere. Akt Rheumatol. 1991; 16: 65–9.

    Article  Google Scholar 

  197. 197.

    Jamali F, Mehvar R, Russell AS, et al. Human pharmacokinetics of ibuprofen enantiomers following different doses and formulations: intestinal chiral inversion. J Pharm Sci. 1992; 81: 221–5.

    PubMed  CAS  Article  Google Scholar 

  198. 198.

    Levine MAH, Walker SE, Paton TW. The effect of food or sucralfate on the bioavailability of S (+) and R(−) enantiomers of ibuprofen. J Clin Pharmacol. 1992; 32: 1110–4.

    PubMed  CAS  Google Scholar 

  199. 199.

    Oliary J, Tod M, Nicolas P, et al. Pharmacokinetics of ibuprofen enantiomers after single and repeated doses in man. Biopharm Drug Disp. 1992; 13: 337–44.

    CAS  Article  Google Scholar 

  200. 200.

    Rudy AC, Bradley JD, Ryan SI, et al. Variability in the disposition of ibuprofen enantiomers in osteoarthritic patients. Ther Drug Monitor. 1992; 14: 464–70.

    CAS  Article  Google Scholar 

  201. 201.

    Hall SD, Rudy AC, Knight PM, et al. Lack of presystemic inversion of (R)- to (S)-ibuprofen in humans. Clin Pharmacol Ther. 1993; 53: 393–400.

    PubMed  CAS  Article  Google Scholar 

  202. 202.

    Geisslinger G, Stock KP, Loew D, et al. Variability in the stereoselective disposition of ibuprofen in patients with rheumatoid arthritis. Br J Clin Pharmacol. 1993; 35: 603–7.

    PubMed  CAS  Article  Google Scholar 

  203. 203.

    Li G, Treiber G, Maier K, et al. Disposition of ibuprofen in patients with liver cirrhosis: stereochemical considerations. Clin Pharmacokinet. 1993; 25: 154–63.

    PubMed  CAS  Article  Google Scholar 

  204. 204.

    Walker JS, Knihinicki RD, Seideman P, et al. Pharmacokinetics of ibuprofen enantiomers in plasma and suction blister fluid in healthy volunteers. J Pharm Sci. 1993; 82: 787–90.

    PubMed  CAS  Article  Google Scholar 

  205. 205.

    Chen C-Y, Chen C-S. Stereoselective disposition of ibuprofen in patients with renal dysfunction. J Pharm Exp Ther. 1994; 258: 590–4.

    Google Scholar 

  206. 206.

    Smith DE, Paliwal JK, Cox SR, et al. The effect of competitive and non-linear plasma protein binding on the stereoselective disposition and metabolic inversion of ibuprofen in healthy subjects. Biopharm Drug Disp. 1994; 15: 545–61.

    CAS  Article  Google Scholar 

  207. 207.

    Bannwarth B, Lapique F, Pehourq F, et al. Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid. Br J Clin Pharmacol. 1995; 40: 266–9.

    PubMed  CAS  Article  Google Scholar 

  208. 208.

    Chen C-Y. Influence of age on the stereoselective disposition and metabolism of ibuprofen in humans. J Formos Med Assoc. 1995; 94: 95–100.

    PubMed  CAS  Google Scholar 

  209. 209.

    Chen C-Y, Chen C-S. Stereoselective disposition of ibuprofen in patients with compromised renal haemodynamics. Br J Clin Pharmacol. 1995; 40: 67–2.

    PubMed  CAS  Article  Google Scholar 

  210. 210.

    Knights KM, McLean CF, Tonkin AL, et al. Lack of effect of gender and oral contraceptive steroids on the pharmacokinetics of (R)-ibuprofen in humans. Br J Clin Pharmacol. 1995; 40: 153–6.

    PubMed  CAS  Article  Google Scholar 

  211. 211.

    Cooper SA, Cowan A, Tallarida RJ, et al. The analgesic interaction of misoprostol with nonsteroidal anti-inflammatory drugs. Am J Ther. 1996; 3: 261–7.

    PubMed  Article  Google Scholar 

  212. 212.

    Siemon D, de Vries JX, Stozer F, et al. Fasting and postprandial disposition of R(−) and S(+)-ibuprofen. J Med Res. 1997; 2: 215–9.

    CAS  Google Scholar 

  213. 213.

    Fornasini G, Monti N, Brogin G. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers. Chirality. 1997; 9: 297–302.

    PubMed  CAS  Article  Google Scholar 

  214. 214.

    Hummel T, Cramer O, Mohammadian P, et al. Comparison of the antinociception produced by two oral formulations of ibuprofen: ibuprofeneffervescent vs ibuprofen tablets. Eur J Clin Pharmacol. 1997; 52: 107–14.

    PubMed  CAS  Article  Google Scholar 

  215. 215.

    Suri A, Grundy BL, Derendorf H. Pharmacokinetics and pharmacodynamics of enantiomers of ibuprofen and flurbiprofen after oral administration. In J Clin Pharmacol Ther. 1997; 35(1): 1–8.

    CAS  Google Scholar 

  216. 216.

    Adams SS, Bough RG, Cliffe EE, et al. Some aspects of the pharmacology, metabolism and toxicology of ibuprofen. Rheumatol Phys Med 1970; Suppl. 9: 9–26.

    Google Scholar 

  217. 217.

    Wagner JG, Albert KS, Szpunar GJ, et al. Pharmacokinetics of ibuprofen in man IV: absorption and disposition. J Pharmacokinet Biopharm. 1984; 12: 381–99.

    PubMed  CAS  Google Scholar 

  218. 218.

    Janssen GME, Venema JF. Ibuprofen: plasma concentrations in man. J Int Med Res. 1985; 13: 68–73.

    PubMed  CAS  Google Scholar 

  219. 219.

    Wagener HH, Vögtle-Junkert U. Intrasubject variability in bioequivalence studies illustrated by the example of ibuprofen. Int J Clin Pharm Ther. 1996; 34: 21–31.

    CAS  Google Scholar 

  220. 220.

    Geisslinger G, Dietzel K, Bezler H, et al. Therapeutically relevant differences in the pharmackinetical and pharmaceutical behavior of ibuprofen lysinate as compared to ibuprofen acid. Int J Clin Pharmacol Ther Toxicol. 1989; 27: 324–8.

    PubMed  CAS  Google Scholar 

  221. 221.

    Adams SS, Warwick Buckler J. Ibuprofen and flurbiprofen. Clin Rheum Dis. 1979; 5: 359–78.

    Google Scholar 

  222. 222.

    Averginos A, Noormohammadi A, Hutt AJ. Disposition of ibuprofen enantiomers following the oral administration of a novel controlled release formulation to healthy volunteers. Int J Pharm. 1991; 68: 97–103.

    Article  Google Scholar 

  223. 223.

    Zhao GL, Wang HC. Drug release kinetics of ibuprofen coated granules and their in vitro in vivo correlation. Acta Pharm Sin. 1995; 30: 291–7.

    CAS  Google Scholar 

  224. 224.

    Paliwal JK, Smith DE, Cox SR, et al. Stereoselective, competitive, and nonlinear plasma protein binding of ibuprofen enantiomers as determined in vivo in healthy subjects. J Pharmacokinet Biopharm. 1993; 21: 145–61.

    PubMed  CAS  Google Scholar 

  225. 225.

    Dominikus M, Nicolakis M, Kotz R, et al. Comparison of tissue and plasma levels of ibuprofen after oral and topical administration. Arzneimittel Forschung. 1996; 46(2): 1138–43.

    Google Scholar 

  226. 226.

    Mondino A, Zanalo G, Giacheeti C, et al. Humankinetische Untersuchungen mit ibuprofen. Med Welt. 1983; 34: 1052–4.

    PubMed  CAS  Google Scholar 

  227. 227.

    Kaiser DG, Vangiessen GJ, Reischer RJ, et al. Isomeric inversion of ibuprofen (R)-enantiomer in humans. J Pharm Sci. 1976; 2: 269–73.

    Article  Google Scholar 

  228. 228.

    Wechter WJ, Loughead DG, Reischer RJ, et al. Enzymatic inversion at saturated carbon: nature and mechanism of the inversion of R(−)p-iso-butyl hydratropic acid. Biochem Biophys Res Commun. 1974; 61: 833–7.

    PubMed  CAS  Article  Google Scholar 

  229. 229.

    Cheng H, Rogers JD, Demetriades JL, et al. Pharmacokinetics and bioinversion of ibuprofen enantiomers in humans. Pharm Res. 1994; 11: 824–30.

    PubMed  CAS  Article  Google Scholar 

  230. 230.

    Cox SR. Effect of route of administration on the chiral inversion of R(−)-ibuprofen [abstract]. Clin Pharmacol Ther. 1988; 21: 146.

    Google Scholar 

  231. 231.

    Mehvar R, Jamali F. Pharmacokinetic analysis of the enantiomeric inversion of chiral nonsteroidal antiinflammatory drags. Pharm Res. 1988; 5: 76–9.

    PubMed  CAS  Article  Google Scholar 

  232. 232.

    Romero AJ, Rackley RJ, Rhodes CT. An evaluation of ibuprofen bioinversion by simulation. Chirality. 1991; 3: 418–21.

    PubMed  CAS  Article  Google Scholar 

  233. 233.

    Rudy AC, Knight PM, Brater DC, et al. Enantioselective disposition of ibuprofen in elderly persons with and without renal impairment. J Pharmacol Exp Ther. 1995; 273: 88–93.

    PubMed  CAS  Google Scholar 

  234. 234.

    Sawchuk RJ, Rector TS. Drug kinetics in burn patients. Clin Pharmacokinet. 1980; 5: 548–56.

    PubMed  CAS  Article  Google Scholar 

  235. 235.

    Albert KS, Gernaat CM. Pharmacokinetics of ibuprofen. Am J Med. 1984; 23: 40–6.

    Article  Google Scholar 

  236. 236.

    Whitlam JB, Brown KR. Ultrafiltration in serum protein binding determinations. J Pharm Sci. 1981; 70: 146–50.

    PubMed  CAS  Article  Google Scholar 

  237. 237.

    Whitlam JB, Crooks MJ, Brown KF, et al. Binding of non-steroidal anti-inflammatory agents to proteins. I: ibuprofen-serum albumin interaction. Biochem Pharmacol. 1979; 28: 675–8.

    CAS  Google Scholar 

  238. 238.

    Wanwimolrak S, Birkett DJ, Brooks PM. Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis. Clin Pharmacokinet. 1982; 7: 85–92.

    Article  Google Scholar 

  239. 239.

    Vowles DT, Marchant B. Protein binding of ibuprofen and its relationship to drag interactions. Br J Clin Pract Symp Suppl. 1980; 1: 13–9.

    Google Scholar 

  240. 240.

    Kober A, Sjöholm I. The binding sites on human serum albumin for some nonsteroidal anti-inflammatory drugs. Mol Pharmacol. 1980; 18: 421–6.

    PubMed  CAS  Google Scholar 

  241. 241.

    Montero MT, Estelrich J, Vails O. Binding of non-steroidal anti-inflammatory drugs to human serum albumin. Int J Pharm. 1990; 62: 21–5.

    CAS  Article  Google Scholar 

  242. 242.

    Honoré B, Brodersen R. Albumin binding of anti-inflammatory drags: utility of a site-oriented versus a stoichiometric analysis. Mol Pharmacol. 1983; 25: 137–50.

    Google Scholar 

  243. 243.

    Lockwood GF, Albert KS, Szupunar GJ, et al. Pharmacokinetics of ibuprofen in man — III: plasma protein binding. J Pharm Biopharm. 1983; 11: 469–82.

    CAS  Google Scholar 

  244. 244.

    Sudlow G, Birkett DJ, Wade DN. Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol. 1976; 12: 1052–61.

    PubMed  CAS  Google Scholar 

  245. 245.

    Noctor TAG, Pham CD, Kaliszan R, et al. Stereochemical aspects of benzodiazepine binding to human serum albumin — 1: enantioselective high performance liquid affinity chromaotgraphic examination of chiral and achiral binding interactions between 1,4-benzodiazepines and human serum albumin. J Pharm Exp Ther. 1992; 42: 506–11.

    CAS  Google Scholar 

  246. 246.

    Hage DS, Noctor TAG, Wainer IW. Characterization of the protein binding of chiral drugs by high-performance affinity chromatography interactions of R- and S-ibuprofen with human serum albumin. J Chromatogr. 1995; 693: 23–32.

    CAS  Article  Google Scholar 

  247. 247.

    Hansen T, Day R, Williams K, et al. The assay and in vitro binding of the enantiomers of ibuprofen. Clin Exp Pharmacol Physiol. 1985; 9: 82–3.

    Google Scholar 

  248. 248.

    Evans AM, Nation RL, Sansom LN, et al. Stereoselective plasma protein binding of ibuprofen enantiomers. Eur J Clin Pharmacol. 1989; 36: 283–90.

    PubMed  CAS  Article  Google Scholar 

  249. 249.

    Cheravallath VK, Riley CM, Narayanan SR, et al. A quantitative circular dichroic investigation of the binding of the enantiomers of ibuprofen and diclofenac to human serum albumin. J Pharm Biomed Anal. 1997; 15: 1719–24.

    Article  Google Scholar 

  250. 250.

    Cheravallath VK, Riley CM, Narayanan SR, et al. The effect of octanoic acid on the binding of the enantiomers of ibuprofen and diclofenac to human serum albumin: a Chromatographic implication. Pharm Res. 1996; 13: 173–8.

    Article  Google Scholar 

  251. 251.

    Glass RC, Swannell AJ. Concentrations of ibuprofen in serum and synovial fluid from patients with arthritis. Br J Clin Pract Sym Suppl. 1978; 6: 453P–54P.

    CAS  Google Scholar 

  252. 252.

    Whitlam JB, Brown KF, Crooks MJ, et al. Transsynovial distribution of ibuprofen in arthritic patients. Clin Pharmacol Ther. 1981; 29: 487–92.

    PubMed  CAS  Article  Google Scholar 

  253. 253.

    Rau R, Berner G, Wagener HH, et al. Konzentration von ibuprofen und eiwess-gehalt sowie pH-wert in kniegelenkserguss und plasma nach oraler gabe von ibuprofen bei arthritis-patienten. Arzneimittel Forschung. 1989; 39: 1166–8.

    PubMed  CAS  Google Scholar 

  254. 254.

    Seideman P, Lohrer F, Graham GG, et al. The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid. Br J Clin Pharm. 1994; 38: 221–7.

    CAS  Article  Google Scholar 

  255. 255.

    Fears S. Lipophilic xenobiotic conjugates: the pharmacological and toxicological consequences of the participation of drugs and other foreign compounds as substrates in lipid biosynthesis. Prog Lipid Res. 1985; 24: 177–95.

    PubMed  CAS  Article  Google Scholar 

  256. 256.

    Williams K, Day R, Knihinicki R, et al. The stereoselective uptake of ibuprofen into adipose tissue. Biochem Pharmacol. 1986; 35: 3403–5.

    PubMed  CAS  Article  Google Scholar 

  257. 257.

    McGeer Pl, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: a review of 17 epidemiologic studies. Neurology. 1996; 47(2): 425–32.

    PubMed  CAS  Article  Google Scholar 

  258. 258.

    Peters H, Chlud K, Berner G et al. Zur perkutanen kinetik von ibuprofen. Akt Rheumatol. 1987; 12: 208–11.

    Article  Google Scholar 

  259. 259.

    Chlud K, Berner G, Wagener HH. Ibuprofenkonzentrationen in subkutanem fettgewebe, gelenkkapsel und synovialflüssigkeit nach perkutaner anwendung. Therapiewoche. 1985; 35: 2872–6.

    Google Scholar 

  260. 260.

    Menzel EJ, Kolarz G. Bindungsvermögen von ibuprofen an humanes gewebe. Arzneimittel Forschung. 1992; 42: 325–7.

    PubMed  CAS  Google Scholar 

  261. 261.

    Menzel EJ, Kolarz G. Bindungsvermogen von ibuprofen an kollagen und andere bindegewebskomponenten. Arzneimittel Forschung. 1990; 40: 481–3.

    PubMed  CAS  Google Scholar 

  262. 262.

    Steinmetz JC, Lee CY, Wu A-Y. Tissue levels of ibuprofen after fatal overdosage of ibuprofen and acetaminophen. Vet Hum Toxicol. 1987; 29: 381–3.

    PubMed  CAS  Google Scholar 

  263. 263.

    Hutt AJ, Caldwell J. The metabolic chiral inversion of 2-arylpropionic acids-a novel route with pharmacological consequences. J Pharm Pharmacol. 1983; 35: 693–704.

    PubMed  CAS  Article  Google Scholar 

  264. 264.

    Mayer JM. Stereoselective metabolism of anti-inflammatory 2-arylpropionates. Acta Pharm Nord. 1990; 2: 197–216.

    PubMed  CAS  Google Scholar 

  265. 265.

    Nakamura Y, Yamaguchi T, Takahashi S, et al. Optical isomerization mechanism of R(−)-hydratropic acid derivatives [abstract]. J Pharmacobiodyn. 1981; 4: S–1.

    Google Scholar 

  266. 266.

    Knihiniicki RD, Day RO, Williams KM. Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drags — I: in vitro studies of ibuprofen and flurbiprofen. Biochem Pharmacol. 1989; 38: 4389–95.

    Article  Google Scholar 

  267. 267.

    Knihiniicki RD, Day RO, Williams KM. Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drags — II: racemization and hydrolysis of (R)- and (S)-ibuprofen CoA thioesters. Biochem Pharmacol. 1991; 42: 1905–11.

    Article  Google Scholar 

  268. 268.

    Brugger R, Aliá BG, Reichel C, et al. Isolation and characterization of rat liver microsomal R-ibuprofenoyl-CoA synthetase. Biochem Pharmacol. 1996; 52: 1007–13.

    PubMed  CAS  Article  Google Scholar 

  269. 269.

    Chen C-Y, Lu P-H, Chen C-S. Metablic inversion of stereoisomeric ibuprofen in man. J Formos Med Assoc. 1991; 90: 437–42.

    PubMed  CAS  Google Scholar 

  270. 270.

    Chen C-S, Shieh W-R, Lu P-H, et al. Metabolic stereoisomeric inversion of ibuprofen in mammals. Biochem Biophy Acta. 1991; 1078: 411–7.

    CAS  Article  Google Scholar 

  271. 271.

    Tracy TS, Hall SD. Metabolic inversion of (R)-ibuprofen epimerization and hydrolysis of ibuprofenyl-coenzyme A. Drug Metab Disp. 1991; 20: 322–7.

    Google Scholar 

  272. 272.

    Tracy TS, Wirthwein DP, Hall SD. Metabolic inversion of (R)-ibuprofen: formation of ibuprofenyl-coenzyme A. Drug Metab Disp. 1992; 21: 114–20.

    Google Scholar 

  273. 273.

    Menzel S, Waibel R, Brune K, et al. Is the formation of R-ibuprofenyl-adenylate the first stereoslective step of chrial inversion? Biochem Pharmacol. 1994; 48(5): 1056–8.

    PubMed  CAS  Article  Google Scholar 

  274. 274.

    Rudy AC, Knight PM, Brater DC, et al. Stereoselective metabolism of ibuprofen in humans: administration of R-, S- and racemic ibuprofen. J Pharmacol Exp Ther. 1991; 259: 1133–9.

    PubMed  CAS  Google Scholar 

  275. 275.

    Leeman TD, Tanson C, Bonnabry C, et al. A major role for cytochrome P450tb (CYP2C) subfamily in the actions of non-steroidal anti-inflammatory drugs. Drugs Exp Clin Res. 1993; 19: 189–95.

    Google Scholar 

  276. 276.

    Hamman MA, Thompson GA, Hall SD. Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C. Biochem Pharmacol. 1997; 54: 33–41.

    PubMed  CAS  Article  Google Scholar 

  277. 277.

    Castillo M, Lam F, Dooley MA, et al. Disposition and covalent binding of ibuprofen and its acylglucuronide in the elderly. Clin Pharmacol Ther. 1995; 57: 636–44.

    PubMed  CAS  Article  Google Scholar 

  278. 278.

    Spraul M, Hofmann, Dvortsak P, et al. High-performance liquid chromatography coupled to high-field proton nuclear magnetic resonance spectroscopy: application to the urinary metabolites of ibuprofen. Anal Chem. 1993; 65: 327–30.

    PubMed  CAS  Article  Google Scholar 

  279. 279.

    Wilson ID, Nicholson JK. Solid-phase extraction chromatography and nuclear magnetic resonance spectrometry for the identification and isolation of drug metabolites in urine. Anal Chem 1987; 2830–22.

  280. 280.

    Spraul M, Hofmann M, Dvortsak P, et al. Liquid chromatography coupled with high-field proton NMR for profiling human urine for endogenous compunds and drug metabolites. J Pharm Biomed Anal. 1992; 10(8): 601–5.

    PubMed  CAS  Article  Google Scholar 

  281. 281.

    Keep DR, Sidelmann UG, Hansen SH. Isolation and characterization of major phase I and II metabolites of ibuprofen. Pharm Res. 1997; 14(5): 676–80.

    Article  Google Scholar 

  282. 282.

    Tan SC, Baker JA, Stevens N, et al. Synthesis, Chromatographic resolution and chiroptical properties of carboxyibuprofen stereoisomers: major metabolites of ibuprofen in man. Chirality. 1997; 9: 75–87.

    PubMed  Article  Google Scholar 

  283. 283.

    El Mouelhi M, Ruelius HW, Fenselau C, et al. Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids diclofenac, ibuprofen and benoxaprofen. Drug Metab Disp. 1987; 15: 767–72.

    CAS  Google Scholar 

  284. 284.

    Pettersen JE, Ulsaker GA, Jellum E. Studies on the metabolism of 2,4′-isobutylphenylpropionic acid (ibuprofen) by gas chromatography and mass spectrometry. J Chromatogr. 1978; 145: 413–20.

    PubMed  CAS  Article  Google Scholar 

  285. 285.

    Shirley MA, Guan X, Kaiser DG, et al. Taurine conjugation of ibuprofen in humans and in rat liver in vitro: relationship to metabolic chiral inversion. J Pharm Exp Ther. 1994; 269: 1166–75.

    CAS  Google Scholar 

  286. 286.

    Chen CS, Chen T, Shieh WR. Metabolic stereoisomeric inversion of 2-arylpropionic acids: on the mechanism of ibuprofen epimerization in rats. Biochim Biophys Acta. 1990; 1033(1): 1–6.

    PubMed  CAS  Article  Google Scholar 

  287. 287.

    Chen CS, Shieh WR, Lu PH. Metabolic stereoisomeric inversion of ibuprofen in mammals. Biochim Biophys Acta. 1991; 1078(3): 411–7.

    PubMed  CAS  Article  Google Scholar 

  288. 288.

    Schneider HT, Nuernberg B, Dietzel K, et al. Biliary elimination of non-steroidal anti-inflammatory drugs. Br J Clin Pharmacol. 1990; 29: 127–31.

    PubMed  CAS  Article  Google Scholar 

  289. 289.

    Rudy AC, Anliker KS, Hall SD. High-performance liquid Chromatographic determination of the stereochemical metabolites of ibuprofen. J Chromatogr. 1990; 528: 395–405.

    PubMed  CAS  Article  Google Scholar 

  290. 290.

    Committee on Drugs, American Academy of Pediatrics. Transfer of drugs and other chemicals into human milk. Pediatrics. 1989; 79: 223–8.

    Google Scholar 

  291. 291.

    Weibert RT, Townsend RJ, Kaiser DG, et al. Lack of ibuprofen secretion into milk. Clin Pharm 1982; 457–8.

  292. 292.

    Townsend RJ, Benedetti TJ, Erickson SH, et al. Excretion of ibuprofen into breast milk. Am J Obstet Gynecol. 1984; 149: 184–6.

    PubMed  CAS  Google Scholar 

  293. 293.

    Walter K, Dilger C. Ibuprofen in human milk. Br J Pharmacol. 1997; 44(2): 211–2.

    CAS  Google Scholar 

  294. 294.

    Kimura T, Shirota O, Ohtsu Y. Analysis of ibuprofen metabolites by semi-microcolumn liquid chromatography with ultraviolet absorption and pulsed amperometric detectors. J Pharm Biomed Anal. 1997; 15: 1521–6.

    PubMed  CAS  Article  Google Scholar 

  295. 295.

    Wechter WJ. Understanding the chiral pharmacology of nonsteroidal antiinflammatory drugs in the aryl propionic acid class. J Clin Pharmacol. 1996; 36 Suppl. 12: 1S–2S.

    PubMed  CAS  Google Scholar 

  296. 296.

    Evans AM. Pharmacodynamics and pharmacokinetics of the profens: enantioselectivity, clinical implications, and special reference to S(+)-ibuprofen. J Clin Pharmacol. 1996; 36 Suppl. 12: 7S–15S.

    PubMed  CAS  Google Scholar 

  297. 297.

    Reichel C, Bang H, Brune K, et al. 2-Arylpropionyl-CoA epimerase: partial peptide sequences and tissue localization. Biochem Pharmacol. 1995; 50: 1803–6.

    PubMed  CAS  Article  Google Scholar 

  298. 298.

    Meyer JM. Ibuprofen enantiomers and lipid metabolism. J Clin Pharmacol. 1996; 36 Suppl. 12: 27S–32S.

    Google Scholar 

  299. 299.

    Ahn H-Y, Jamali F, Cox SR, et al. Stereospelective disposition of ibuprofen enantiomers in the isolated perfused rat kidney. Pharm Res. 1991; 8: 1520–4.

    PubMed  CAS  Article  Google Scholar 

  300. 300.

    Cox PGE, Moons WM, Russel FGM, et al. Renal handling and effects of S(+)-ibuprofen and R(−)-ibuprofen in the rat isolated perfused kidney. Br J Pharmacol. 1991; 103: 1542–6.

    PubMed  CAS  Article  Google Scholar 

  301. 301.

    Caldwell J, Hutt AJ, Fournel-Gigleux S. The metabolic chiral inversion and disposition enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochem Pharmacol. 1988; 37: 105–14.

    PubMed  CAS  Article  Google Scholar 

  302. 302.

    Knihiniicki RD, Day RO, Graham GG, et al. Stereoselective disposition of ibuprofen and flurbiprofen in rats. Chirality. 1990; 2: 134–40.

    Article  Google Scholar 

  303. 303.

    Leising G, Resel R, Tash S, et al. Physical aspects of dexibuprofen and racemic ibuprofen. J Clin Pharmacol. 1996; 36 Suppl. 12: 3S–6S.

    PubMed  CAS  Google Scholar 

  304. 304.

    Dwivedi SK, Mitchell AG, Sattari S, et al. Ibuprofen racemate and enantiomers: phase diagram, solubility and thermodynamic studies. Int J Pharm. 1992; 87: 95–104.

    Article  Google Scholar 

  305. 305.

    Klein G, Neff H, Kullich W, et al. S(+) versus racemic ibuprofen [letter]. Lancet. 1992; 339: 681.

    PubMed  CAS  Article  Google Scholar 

  306. 306.

    Chlud K. Evaluation of tolerance and efficacy of S(+)-ibuprofen (Seractil®) in daily practice: a post-marketing-surveillance study in 1400 patients. J Clin Pharmacol. 1995; 35: 921–4.

    Google Scholar 

  307. 307.

    Stock KP, Geisslinger G, Loew D, et al. S-ibuprofen versus ibuprofen-racemate. Rheumatol Int. 1991; 11: 199–202.

    PubMed  CAS  Article  Google Scholar 

  308. 308.

    Cullen DJ, Hudson N, Atherton JC, et al. Gastric tolerability of S(+) ibuprofen compared to racemic ibuprofen [abstract]. Gastroenterology. 1995; 108: A78.

    Google Scholar 

  309. 309.

    Neupert W, Brugger R, Euchenhofer C, et al. Effects of ibuprofen enantiomers and its coenzyme A thioester on human prostaglandin endoperoxide synthases. Br J Pharmacol. 1997; 122: 487–92.

    PubMed  CAS  Article  Google Scholar 

  310. 310.

    Freneaux E, Fromety B, Berson A, et al. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial β-oxidation of fatty acids. J Pharm Exp Ther. 1990; 255: 529–35.

    CAS  Google Scholar 

  311. 311.

    Zhao B, Geisslinger G, Hall I, et al. The effect of the enantiomers of ibuprofen and flurbiprofen on the β-oxidation of palmitate in the rat. Chirality. 1992; 4: 137–41.

    PubMed  CAS  Article  Google Scholar 

  312. 312.

    Reichel C, Brugger R, Bang H, et al. Molecular cloning and expression of a 2-arylpropionyl-coenzyme a epimerase: a key enzyme in the inversion metabolism of ibuprofen. Mol Pharmacol. 1997; 51: 576–82.

    PubMed  CAS  Google Scholar 

  313. 313.

    Konstan MW, Byard PJ, Hoppel CL, et al. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med. 1995; 332: 848–54.

    PubMed  CAS  Article  Google Scholar 

  314. 314.

    Laska EM, Sunshine A, Marrero I. The correlation between blood levels of ibuprofen and analgesic response. Clin Pharmacol Ther. 1986; 40(1): 1–7.

    PubMed  CAS  Article  Google Scholar 

  315. 315.

    Greenan DW, Aarons L, Siddiqui M, et al. Dose-response study with ibuprofen in rheumatoid arthritis: clinical and pharmacokinetic findings. Br J Clin Pharmacol. 1983; 15: 311–6.

    Article  Google Scholar 

  316. 316.

    Grennan DM, Ferry DG, Ashworth ME, et al. The aspirinibuprofen interaction in rheumatoid arthritis. Br J Clin Pharmacol. 1979; 8: 497–503.

    PubMed  CAS  Article  Google Scholar 

  317. 317.

    Bradley JD, Rudy AC, Katz BP, et al. Correlation of serum concentrations of ibuprofen stereoisomers with clinical response in the treatment of hip and knee osteoarthritis. J Rheumatol. 1992; 19: 130–4.

    PubMed  CAS  Google Scholar 

  318. 318.

    Malek KW, Velagapudi RB, Harter JG, et al. Pharmacodynamics of ibuprofen (IB) antipyresis in children [abstract]. Clin Pharmacol Ther. 1990; 20: 232.

    Google Scholar 

  319. 319.

    Garg V, Jusko WJ. Pharmacodynamic modeling of nonsteroidal anti-inflammatory drugs: antipyretic effect of ibuprofen. Clin Pharmacol Ther. 1994; 55: 87–8.

    PubMed  CAS  Article  Google Scholar 

  320. 320.

    Milsom I, Anderch B. Intra-uterine pressure and serum ibuprofen: observations after oral administration of 400 mg ibuprofen to a patient with primary dysmenorrhoea. Eur J Clin Pharmacol. 1985; 29: 443–6.

    PubMed  CAS  Article  Google Scholar 

  321. 321.

    Hall AH, Smolinske SC, Conrad FL, et al. Ibuprofen overdose: 126 cases. Ann Emerg Med. 1986; 15: 1308–13.

    PubMed  CAS  Article  Google Scholar 

  322. 322.

    McElwee NE, Veltri JC, Bradford DC, et al. A prospective, population-based study of acute ibuprofen overdose: complications are rare and routine serum levels are not warranted. Ann Emerg Med. 1990; 19: 657–62.

    PubMed  CAS  Article  Google Scholar 

  323. 323.

    Jenkinson ML, Fitzpatrick R, Streete PJ, et al. The relationship between plasma ibuprofen concentrations and toxicity in acute ibuprofen overdose. Human Toxicol. 1988; 7: 319–24.

    CAS  Article  Google Scholar 

  324. 324.

    Whelton A, Stout RL, Spilman PS, et al. Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison. Ann Intern Med. 1990; 112: 568–76.

    CAS  Google Scholar 

  325. 325.

    Murray MD, Black PK, Kuzmik DD, et al. Acute and chronic effects of nonsteroidal antiinflammatory drugs on glomerular filtration rate in elderly patients. Am J Med Sci. 1995; 310: 188–91.

    PubMed  CAS  Article  Google Scholar 

  326. 326.

    Adamska-Dyniewska, Tkaczewski W, et al. Farmakokinetyka ibuprofenu u chorych z marskoscia watroby. Wiad Lek. 1982; 35: 609–13.

    PubMed  CAS  Google Scholar 

  327. 327.

    Cooper-Peel C, Brodersen R, Robertston A. Does ibuprofen affect bilirubin-albumin binding in newborn infant serum? Pharm Toxicol. 1996; 79(6): 297–9.

    CAS  Article  Google Scholar 

  328. 328.

    Grennan DM, Aarons L. Salicylate-NSAID interactions. Ann Rheum Dis 1994; 43: 351–2.

    Article  Google Scholar 

  329. 329.

    Conrad KA, Mayershohn M, Bliss M. Cimetidine does not alter ibuprofen kinetics after a single dose. Br J Clin Pharmacol. 1984; 18: 624–6.

    PubMed  CAS  Article  Google Scholar 

  330. 330.

    Small RE, Wood JH. Influence of racial differences on effects of ranitidine and cimetidine on ibuprofen pharmacokinetics. Clin Pharm. 1989; 8: 471–2.

    PubMed  CAS  Google Scholar 

  331. 331.

    Nicholson PA, Karim A, Smith M. Pharmacokinetics of misoprostol in the elderly, in patients with renal failure and when co-administered with NSAID or antipyrine, propanolol or diazepam. J Rheumatol 1990; 20 Suppl.: S33–7.

    Google Scholar 

  332. 332.

    Skeith KJ, Russell AS, Jamali F, et al. Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis. J Rheumatol. 1990; 17: 1008–10.

    PubMed  CAS  Google Scholar 

  333. 333.

    Abdullah ME, El-Sayed YM. Design of crossover microcomputer program and application on drug bioequivalence data. Comput Methods Programs Biomed. 1995; 48: 237–9.

    PubMed  CAS  Article  Google Scholar 

  334. 334.

    Ragheb M, Ban TA, Buchanan D, et al. Interaction of indomethacin and ibuprofen with lithium in manic patients under a steady-state lithium level. J Clin Psychiatry. 1980; 41: 397–8.

    PubMed  CAS  Google Scholar 

  335. 335.

    Tracy TS, Krohn K, Jones DR, et al. The effects of a salicylate, ibuprofen, and diclofenac on the disposition of methotrexate in patients with rheumatoid arthritis. Eur J Clin Pharmacol. 1992; 42: 121–5.

    PubMed  CAS  Article  Google Scholar 

  336. 336.

    Quattrocchi FP, Robinson JD, Curry RW, et al. The effects of ibuprofen on serum digoxin concentrations. Drug Intell Clin Pharm. 1983; 17: 286–8.

    PubMed  CAS  Google Scholar 

  337. 337.

    Goncalves I. Influence of ibuprofen on haemostasis in patients on anticoagulant therapy. J Int Med Res. 1973; 1: 180–5.

    Google Scholar 

  338. 338.

    Boekhout-Mussert MJ, Loeliger EA. Influence of ibuprofen on oral anti-coagulation with phenprocoumon. J Int Med Res. 1974; 2: 279–83.

    Google Scholar 

  339. 339.

    Thilo D, Nyman D, Duckert F. A study of the effects of the anti-rheumatic drug ibuprofen (brufen®) on patients being treated with the oral anti-coagulant phenprocoumon (marcoumar®). J Int Med Res. 1974; 2: 276–8.

    Google Scholar 

  340. 340.

    Duckett F. The absence of effect of antirheumatic drug ibuprofen and oral anticoagulation with phenprocoumon. Curr Med Res Op. 1975; 3: 556–7.

    Article  Google Scholar 

  341. 341.

    Penner JA, Abbrecht PH. Lack of interaction between ibuprofen and warfarin. Curr Ther Res. 1975; 18: 862–71.

    PubMed  CAS  Google Scholar 

  342. 342.

    Slattery JT, Levy G. Effect of ibuprofen on protein binding of warfarin in human serum. J Pharm Sci. 1977; 66: 1060.

    PubMed  CAS  Article  Google Scholar 

  343. 343.

    Schulman S, Henriksson K. Interaction of ibuprofen and warfarin on primary haemostasis. Br J Rheumatol. 1989; 28: 46–9.

    PubMed  CAS  Article  Google Scholar 

  344. 344.

    Koopmans PP, Thien TH, Gribnau FWJ. The influence of ibuprofen, diclofenac and sulindac on the blood pressure lowering effect of hydrochlorothiazide. Eur J Clin Pharmacol. 1987; 31: 553–7.

    PubMed  CAS  Article  Google Scholar 

  345. 345.

    Gurwitz JH, Everitt DE, Monane M, et al. The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly patients. J Gerontol 1996; 51A: M74–M79.

    CAS  Article  Google Scholar 

  346. 346.

    Radack KL, Deck CC. Ibuprofen interferes with the efficacy of antihypertensive drugs: a randomized, double-blind, placebocontrolled trial of ibuprofen compared with acetaminophen. Ann Intern Med. 1987; 107: 628–35.

    PubMed  CAS  Google Scholar 

  347. 347.

    Wright JT, McKenney JM, Lehaney AM, et al. The effect of high-dose short-term ibuprofen on antihypertensive control with hydrochlorothiazide. Clin Pharmacol Ther. 1989; 46: 440–4.

    PubMed  CAS  Article  Google Scholar 

  348. 348.

    Minuz P, Lechi A, Arosio E, et al. Antihypertensive activity of enalapril. Effect of ibuprofen and different salt intakes. J Clin Hypertens. 1987; 3: 645–53.

    CAS  Google Scholar 

  349. 349.

    Davies JG, Rawlins DC, Busson M. Effect of ibuprofen on blood pressure control by propranolol and bendrofluazide. J Int Med Res. 1988; 16: 173–81.

    PubMed  CAS  Google Scholar 

  350. 350.

    Hooten WM, Pearlson G. Delirium caused by tacrine and ibuprofen interaction. Am J Psychiatry. 1996; 153: 842.

    PubMed  CAS  Google Scholar 

  351. 351.

    Sandyk R. Phenytoin toxcity induced by interaction with ibuprofen. S Afr Med J. 1982; 62: 592.

    PubMed  CAS  Google Scholar 

  352. 352.

    Bachman KA, Schwartz JI, Forney RB, et al. Inability of ibuprofen to alter single dose phenytoin disposition. Br J Clin Pharmacol. 1986; 21: 165–9.

    Article  Google Scholar 

  353. 353.

    Lee P, Bell MA, Webb J, et al. A study on the effects of ibuprofen on the metabolism of antipyrine in man. Med J Aust. 1973; 2: 846–9.

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Dr Neal M. Davies.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Davies, N.M. Clinical Pharmacokinetics of Ibuprofen. Clin Pharmacokinet 34, 101–154 (1998). https://doi.org/10.2165/00003088-199834020-00002

Download citation

Keywords

  • Adis International Limited
  • Ibuprofen
  • Synovial Fluid
  • Sucralfate
  • Racemate